Keloid Treatment Using Plasma Exeresis: A Pilot Trial Study Plasma exeresis & keloid scars
Journal of Lasers in Medical Sciences,
Vol. 14 (2023),
29 January 2023
,
Page e7
Abstract
Introduction: Keloid scars and hypertrophic scars are more commonly seen after surgeries, suture placements, or other skin damage. Scars can be treated using a variety of methods, including topical compounds, surgery, and lasers. The aim of this study is to evaluate the effects of plasma exeresis on the treatment of keloid scars.
Methods: This experimental study was conducted on patients with keloid scars, defined as a treatment-resistant subtype of scars with extension beyond the primary skin defect and cauliflower appearance, in different parts of the body. The patients were treated with 2-to-3-session plasma exeresis. Scars were examined based on the Vancouver scar scale (VSS) before and 5 months after the treatment.
Results: A total number of 24 scars were enrolled in this study. The number of patients was 16. There was a decrease in the mean thickness of keloids from 2.20 to 0.54 (P=0.000). The mean pigmentation and pliability scores decreased from 1.54 and 2.16 to 0.375 and 0.541, respectively (P=0.001). There was a significant reduction in the keloid scar vascularity score from 1.666 to 0.541 (P=0.000). There was a decrease from 0.708 to 0.00 (P=0.004) in the mean itchiness score. After the intervention, the mean pain score was 0.000, compared to 0.7500 before the intervention (P=0.003). There was a decrease in the total score from 8.958 to 2.000 (P=0.000).
Conclusion: The plasma exeresis procedure is effective in destroying small keloid scars. Furthermore, results in less itching and pain, as well as no significant complications or recurrences.
- Keloid scar; Keloid treatment; Plasma exeresis; Plexr; Skin surgery
How to Cite
References
1. Ogawa R. Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. Int J Mol Sci. 2017;18(3):606. doi: 10.3390/ijms18030606.
2. Berman B, Maderal A, Raphael B. Keloids and hypertrophic scars: pathophysiology, classification, and treatment. Dermatol Surg. 2017;43 Suppl 1:S3-S18. doi: 10.1097/dss.0000000000000819.
3. Alster TS, Tanzi EL. Hypertrophic scars and keloids: etiology and management. Am J Clin Dermatol. 2003;4(4):235-43. doi: 10.2165/00128071-200304040-00003.
4. Rabello FB, Souza CD, Farina Júnior JA. Update on hypertrophic scar treatment. Clinics (Sao Paulo). 2014;69(8):565-73. doi:10.6061/clinics/2014(08)11.
5. Ojeh N, Bharatha A, Gaur U, Forde AL. Keloids: current and emerging therapies. Scars Burn Heal. 2020;6:2059513120940499. doi: 10.1177/2059513120940499.
6. Grabowski G, Pacana MJ, Chen E. Keloid and hypertrophic scar formation, prevention, and management: standard review of abnormal scarring in orthopaedic surgery. J Am Acad Orthop Surg. 2020;28(10):e408-e14. doi: 10.5435/jaaos-d-19-00690.
7. Sotiris TG, Nikolaos G, Irini G. Plexr: the revolution in blepharoplasty. Pinnacle Med Med Sci. 2014;1(5):1-5.
8. Sotirios TG, Nantia S. Non-invasive blepharoplasty with plasma exeresis (Plexr) pre/post treatments. J Aesthetic Reconstr Surg. 2018;4(1):1-4. doi: 10.4172/2472-1905.100040.
9. Stamatina G, Sotiris T, Aglaia V. Plexr in acne treatment. Pinnacle Med Med Sci. 2015;2(1):1-5.
10. Bock O, Schmid-Ott G, Malewski P, Mrowietz U. Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res. 2006;297(10):433-8. doi: 10.1007/s00403-006-0651-7.
11. Limmer EE, Glass DA 2nd. A review of current keloid management: mainstay monotherapies and emerging approaches. Dermatol Ther (Heidelb). 2020;10(5):931-48. doi: 10.1007/s13555-020-00427-2.
12. Aggarwal A, Ravikumar BC, Vinay KN, Raghukumar S, Yashovardhana DP. A comparative study of various modalities in the treatment of keloids. Int J Dermatol. 2018;57(10):1192-200. doi: 10.1111/ijd.14069.
13. Abedini R, Sasani P, Mahmoudi HR, Nasimi M, Teymourpour A, Shadlou Z. Comparison of intralesional verapamil versus intralesional corticosteroids in treatment of keloids and hypertrophic scars: A randomized controlled trial. Burns. 2018;44(6):1482-8. doi: 10.1016/j.burns.2018.05.005.
14. Cannarozzo G, Sannino M, Tamburi F, Morini C, Nisticò SP. Flash-lamp pulsed-dye laser treatment of keloids: results of an observational study. Photomed Laser Surg. 2015;33(5):274-7. doi: 10.1089/pho.2015.3895.
15. Eke U, Diaz C, Abdullah A. Keloid scars in type VI skin successfully treated with combined surgery and pulsed dye laser therapy. Br J Dermatol. 2013;168(6):1360-2. doi: 10.1111/bjd.12159.
16. Payapvipapong K, Niumpradit N, Piriyanand C, Buranaphalin S, Nakakes A. The treatment of keloids and hypertrophic scars with intralesional bleomycin in skin of color. J Cosmet Dermatol. 2015;14(1):83-90. doi: 10.1111/jocd.12132.
17. Litrowski N, Boullie MC, Dehesdin D, De Barros A, Joly P. Treatment of earlobe keloids by surgical excision and cryosurgery. J Eur Acad Dermatol Venereol. 2014;28(10):1324-31. doi: 10.1111/jdv.12282.
18. Azzam EZ, Omar SS. Treatment of auricular keloids by triple combination therapy: surgical excision, platelet-rich plasma, and cryosurgery. J Cosmet Dermatol. 2018;17(3):502-10. doi:10.1111/jocd.12552.
19. Kraeva E, Ho D, Jagdeo J. Successful treatment of keloid with fractionated carbon dioxide (CO2) laser and laser assisted drug delivery of triamcinolone acetonide ointment in an African-American man. J Drugs Dermatol. 2017;16(9):925-7.
20. Yang Q, Ma Y, Zhu R, Huang G, Guan M, Avram MM, et al. The effect of flashlamp pulsed dye laser on the expression of connective tissue growth factor in keloids. Lasers Surg Med. 2012;44(5):377-83. doi: 10.1002/lsm.22031.
21. Wong TW, Lee JY, Sheu HM, Chao SC. Relief of pain and itch associated with keloids on treatment with oxpentifylline. Br J Dermatol. 1999;140(4):771-2.
22. Weshay AH, Abdel Hay RM, Sayed K, El Hawary MS, NourEdin F. Combination of radiofrequency and intralesional steroids in the treatment of keloids: a pilot study. Dermatol Surg. 2015;41(6):731-5. doi: 10.1097/dss.0000000000000360.
23. Ting W, Chong Y, Xu J, Huang J, Yu N, Liu Z. Treatment of keloids using plasma skin regeneration combined with radiation therapy under the evaluation of patient and observer scar assessment scale. Clin Cosmet Investig Dermatol. 2021;14:981-9. doi: 10.2147/ccid.s321348.
24. Sotiris TG, Nittari G, Sagaro GG, Amenta F. A descriptive study on the applications of plasma exeresis in dermatology. J Clin Aesthet Dermatol. 2021;14(3):E58-E62.
25. Kono T, Groff WF, Sakurai H, Yamaki T, Soejima K, Nozaki M. Treatment of traumatic scars using plasma skin regeneration (PSR) system. Lasers Surg Med. 2009;41(2):128-30. doi: 10.1002/lsm.20723.
26. Arno AI, Gauglitz GG, Barret JP, Jeschke MG. Up-to-date approach to manage keloids and hypertrophic scars: a useful guide. Burns. 2014;40(7):1255-66. doi: 10.1016/j.burns.2014.02.011.
27. Garg GA, Sao PP, Khopkar US. Effect of carbon dioxide laser ablation followed by intralesional steroids on keloids. J Cutan Aesthet Surg. 2011;4(1):2-6. doi: 10.4103/0974-2077.79176.
28. Hersant B, SidAhmed-Mezi M, Picard F, Hermeziu O, Rodriguez AM, Ezzedine K, et al. Efficacy of autologous platelet concentrates as adjuvant therapy to surgical excision in the treatment of keloid scars refractory to conventionaltreatments: a pilot prospective study. Ann Plast Surg. 2018;81(2):170-5. doi: 10.1097/sap.0000000000001448.
29. Fitzpatrick R, Bernstein E, Iyer S, Brown D, Andrews P, Penny K. A histopathologic evaluation of the plasma skin regeneration system (PSR) versus a standard carbon dioxide resurfacing laser in an animal model. Lasers Surg Med.2008;40(2):93-9. doi: 10.1002/lsm.20547.
30. Foster KW, Moy RL, Fincher EF. Advances in plasma skin regeneration. J Cosmet Dermatol. 2008;7(3):169-79. doi:10.1111/j.1473-2165.2008.00385.x.
- Abstract Viewed: 510 times
- PDF Downloaded: 566 times